Category: Patient Safety & Outcomes

Facial recognition difficulties may be linked to long COVID

Further research into the effects of long COVID-19 has revealed that in addition to the myriad neurological symptoms that have been linked to the disease, face blindness may also be one of them.

Facial recognition difficulties may be linked to long COVID

Further research into the effects of long COVID-19 has revealed that in addition to the myriad neurological symptoms that have been linked to the disease, face blindness may also be one of them.

How a shortage of biomedical technicians could affect hospitals

A looming shortage of biomedical technicians and engineers, plus the closure of their programs, spells concern for the profession, according to the Association for the Advancement of Medical Instrumentation.

Healthcare leaders, staff differ on safety culture views: Report

Clinical and nonclinical healthcare workers have an upward-trending perception of safety culture, but physicians and leaders do not agree, according to a Press Ganey report released March 16. 

This NIH center has brought 44 drugs for rare diseases to market — and isn't slowing down

In just the 12 years since its establishment, the National Center for Advancing Translational Sciences has brought 44 FDA-approved drugs for rare diseases to the market — and it shows no signs of slowing down.

Northwestern surgeons perform double lung transplant in 2 cancer patients

Northwestern Medicine is pioneering a new treatment for stage 4 cancer patients: double lung transplants.

Do strikes harm patients? Evidence is limited

The narrative that strikes threaten patient safety is not substantiated by current evidence, researchers wrote in a March 10 analysis published in The BMJ. 

US maternal mortality hits 58-year high

The rate of maternal deaths during or shortly after pregnancy rose 40 percent in 2021, making the U.S. the most dangerous place among high-income countries to give birth, The Wall Street Journal reported March 16.

Tampa General opens 1st limb loss prevention program in region

Tampa (Fla.) General Hospital’s Heart and Vascular Institute has opened a new clinic designated to house what it claims is the “first and only” limb preservation program in the region. 

COVID-19 rebound not linked to Paxlovid, FDA says

The FDA reviewed Pfizer’s mid-to-late stage clinical trials of Paxlovid and found “no evidence of a higher rate of symptom rebound or moderate symptom rebound.”